Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Xetra  >  Symrise AG    SY1   DE000SYM9999


Real-time Estimate Quote. Real-time Estimate Tradegate - 10/21 09:33:56 am
114.625 EUR   -0.63%
02:01aQ3 2020 : Strong growth with good profitability
10/20PROBI : acquires shares in Vital Nutrients Holdings and enters into strategic partnership
10/19SYMRISE AG : UBS reaffirms its Neutral rating
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

New clinical data suggests: Symrise anti-dandruff active promotes healthy scalp microbiome

share with twitter share with LinkedIn share with facebook
09/09/2020 | 04:17am EDT

In a clinical study, Symrise has found additional positive effects for Crinipan® PMC green, its novel, plant-based anti-dandruff active. The new molecule is as effective against dandruff as traditional ingredients, and also helps to promote healthy scalp. Application of the ingredient by test subjects with dandruff resulted in a healthier ratio of two dominant species of scalp bacteria. This finding is based on ex vivo samples, that Symrise researchers took from the scalp of study participants, before and after a 30-day application of Crinipan® PMC green. The substance is suitable for use in many types of dandruff control and scalp care products.

Symrise has incorporated modern research technologies on scalp microbiome into its clinical studies. Contemporary scientific literature reports that besides of the well discussed relevance of Malassezia yeast in dandruff formation, also bacteria seem to play a bigger role than assumed in the past. The ratio of propionibacteria to staphylococci on healthy scalp favors propionibacteria, while the opposite applies to scalp with dandruff. Symrise has now discovered that application of Crinipan® PMC green is supporting a favorable shift in this bacterial balance promoting a healthier scalp. At the same time, the researchers observed the opposite effect on the scalps treated with a placebo product.

The active also stands out with its innovative mode of action to target dandruff. Malassezia, known as one of the main causes for dandruff on scalp, activates the ingredient with its enzymes. Symrise has already demonstrated Crinipan® PMC green´s effectiveness in a clinical shampoo study, demonstrating comparable efficacy known from conventional actives like climbazole. Crinipan® PMC green is receiving a great deal of attention, for example by winning the renowned BSB Award 2020 in the category Most Innovative Active Ingredient/Scalp, Barrier, Redness.

"Consumers will be able to use an ingredient that is effective against dandruff as well as supporting healthy scalp," says Dr. Florian Genrich, Senior Global Product Manager Skin Protection in the Cosmetic Ingredients division at Symrise. "We have once again proven our power to innovate, which we base upon more than 45 years of experience in the field of Micro Protection."

Sustainably produced using plant-based raw materials

Another unique characteristic of Crinipan® PMC green lies in its eco-friendly production process, based on 100% renewable raw materials. Symrise also fulfils consumers' desire for cosmetics featuring natural ingredients that deliver effectiveness known from conventional products.

"With Crinipan® PMC green, we are offering an eco-friendly alternative to traditional anti-dandruff actives," says Dr. Christin Koch, Head of Microbiological Research in the Global Innovation Cosmetic Ingredients Division at Symrise. "We plan to develop more and more green products in the future, which will allow us to contribute to climate protection and take responsibility for future generations."


(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

share with twitter share with LinkedIn share with facebook
All news about SYMRISE AG
02:01aQ3 2020 : Strong growth with good profitability
10/20PROBI : acquires shares in Vital Nutrients Holdings and enters into strategic pa..
10/19SYMRISE AG : UBS reaffirms its Neutral rating
10/19PROBI : Presentation of Probi's Q3 report
10/12SYMRISE AG : DZ Bank downgrades from Neutral to Sell rating
10/08SYMRISE AG : Gets a Neutral rating from Bernstein
10/07SYMRISE AG : UBS sticks Neutral
10/05SYMRISE AG : Goldman Sachs remains its Buy rating
10/01SYMRISE AG : JP Morgan remains a Sell rating
10/01SYMRISE AG : Deutsche Bank reaffirms its Buy rating
More news
Sales 2020 3 608 M 4 278 M 4 278 M
Net income 2020 345 M 409 M 409 M
Net Debt 2020 1 425 M 1 690 M 1 690 M
P/E ratio 2020 47,1x
Yield 2020 0,90%
Capitalization 15 621 M 18 478 M 18 522 M
EV / Sales 2020 4,72x
EV / Sales 2021 4,42x
Nbr of Employees 10 413
Free-Float 91,2%
Duration : Period :
Symrise AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SYMRISE AG
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 106,32 €
Last Close Price 115,35 €
Spread / Highest target 17,9%
Spread / Average Target -7,83%
Spread / Lowest Target -29,8%
EPS Revisions
Heinz-Jürgen Bertram Chief Executive Officer
Michael König Chairman-Supervisory Board
Olaf Klinger Chief Financial Officer
Horst-Otto Gerberding Member-Supervisory Board
Peter Winkelmann Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
SYMRISE AG22.97%18 478
ECOLAB INC.5.19%57 936
GIVAUDAN SA28.97%39 763
SIKA AG26.48%35 932